Is the Market Prepa...
Pain Therapeutics Inc. (PTIE: NASDAQ)
$4.13 -0.02 | -0.48%
02/08/12 - 04:00 PM ET
57.95K / 137.80K
Vol / Avg. Vol:4.15 / 4.15
Open / Prev. Close:4.05 - 4.16
Today's Range:3.28 - 10.45
52 Wk Range:9.21%
Performance YTD:TheStreet Rating:
Portfolios with PTIE
- Portfolio NameUser Type
- UserBarron's Insider Purchases ...
- UserBarron's Insider Purchases ...
- Userbigdreamgirl Portfolio 1
- Usercscob Portfolio 1
- UserChoe Pharma
- Usertelger Portfolio 1
- UserStock Rehab, I said, ....&q...
- Userchazzzzz Portfolio 1
- UserTheBartman
- Userironferg Portfolio 1
Latest PTIE Headlines from TheStreet
- Pain Therapeutics Inc. Stock Downgraded (PTIE) 07.04.11 | 08:07 am
- Pain Rises On Unusually High Volume (PTIE) 06.28.11 | 03:06 pm
- Business Highlights 06.24.11 | 06:06 pm
- Pain Stock Falls On Unusually High Volume (PTIE) 06.24.11 | 09:06 am
- Pfizer, Pain Therapeutics Drug Rejected by FDA 06.24.11 | 08:06 am
- Futures Pause Ahead of Expected Weak U.S. Data 06.24.11 | 07:06 am
- 6 Stocks to Watch: ORCL, PTIE, SUG 06.24.11 | 07:06 am
- A Busy Week for Six Biotech Stocks 06.20.11 | 06:06 am
- Pfizer, Acura Painkiller Approved by FDA 06.19.11 | 04:06 pm
- The Next Big Thing In Biotech: Pain Therapeutics
06.18.11 | 12:06 pm
Press Releases for PTIE
- Harwood Feffer LLP Announces Investigation Of Pain Therapeutics, Inc. - Business Wire 01.06.12 | 03:01 pm
- The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Pain Therapeutics, Inc. Of Class Action Lawsuit And The Deadline Of January 31, 2012 To Seek A Lead Plaintiff Position - Business Wire 01.05.12 | 03:01 pm
- Faruqi & Faruqi, LLP Announces Investigation Of Pain Therapeutics, Inc. - Business Wire 12.05.11 | 07:12 pm
- Bronstein, Gewirtz & Grossman, LLC Investigates Miller Energy Resources, Inc. - Business Wire 08.26.11 | 05:08 pm
- Pfizer Receives Complete Response Letter From FDA For REMOXY® - PR Newswire 06.24.11 | 08:06 am
- FDA Complete Response Letter Received For REMOXY - Business Wire 06.24.11 | 08:06 am
- REMOXY® New Drug Application Accepted By The FDA With PDUFA Goal Date Of June 23, 2011 - PR Newswire 01.27.11 | 08:01 am
- REMOXY® New Drug Application Resubmitted - PR Newswire 12.27.10 | 07:12 am
Partner Headlines for PTIE
- 4 Big Losers From Last Week - Seeking Alpha 07.04.11 | 07:07 am
- Morning Market Losers - Benzinga 06.27.11 | 09:06 am
- Friday Options Recap - Seeking Alpha 06.10.11 | 03:06 pm
- 12 Healthcare Companies Looking at June Catalysts - Seeking Alpha 05.30.11 | 04:05 am
- Stocks Lower Despite Positive Housing News; Market Awaits Big Earnings Results, Fed Policy Meeting - NASDAQ 04.25.11 | 04:04 pm
- Mid-Day Update: Stocks Sagging as Investors Eye Earnings, Fed Meeting - NASDAQ 04.25.11 | 04:04 pm
- Stock breaking out new High (PTIE) $9.11 - Benzinga 03.30.11 | 09:03 am
- Pain Therapeutics: Optimistic Indicators, Large Upside Potential - Seeking Alpha 02.08.11 | 09:02 am
- Pfizer's Osteoarthritis Drug Runs Into Unique Roadblock - Seeking Alpha 10.04.10 | 08:10 am
- 6 Ways to Trade FDA and Clinical Trial News - Seeking Alpha 05.28.10 | 02:05 pm





